Articles by Joshua A. Copel, MD

Unjustified Increase in Cost of Care Resulting From U.S. Food and Drug Administration Approval of Makena (17a-Hydroxyprogesterone Caproate)

Cohen, Arnold W.; Copel, Joshua A.; Macones, George A.; More

Obstetrics & Gynecology. 117(6):1408-1412, June 2011.